![Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.bjc.6604999/MediaObjects/41416_2009_Article_BF6604999_Fig4_HTML.gif)
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer
PLOS ONE: PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement
![K17, a prognostic marker in cervical cancer independent of tumor stage.... | Download Scientific Diagram K17, a prognostic marker in cervical cancer independent of tumor stage.... | Download Scientific Diagram](https://www.researchgate.net/profile/Kenneth-Shroyer/publication/282475832/figure/fig1/AS:281668712714245@1444166462921/K17-a-prognostic-marker-in-cervical-cancer-independent-of-tumor-stage-A-hematoxylin.png)
K17, a prognostic marker in cervical cancer independent of tumor stage.... | Download Scientific Diagram
![Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research](https://cdn.amegroups.cn/journals/pbpc/files/journals/5/articles/2729/public/2729-PB3-R1.png/w300)
Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research
![Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial - European Journal of Cancer Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/42c076b9-e534-4b40-bdbc-343bb3f8ced3/gr1.jpg)
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial - European Journal of Cancer
PLOS ONE: Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer
![2 Breast cancer metastasis prognostic markers. Reprinted by permission... | Download Scientific Diagram 2 Breast cancer metastasis prognostic markers. Reprinted by permission... | Download Scientific Diagram](https://www.researchgate.net/profile/Douglas-Kniss/publication/265261050/figure/fig2/AS:669486294261761@1536629379081/Breast-cancer-metastasis-prognostic-markers-Reprinted-by-permission-from-Macmillan.jpg)
2 Breast cancer metastasis prognostic markers. Reprinted by permission... | Download Scientific Diagram
![Systematic review: prognostic tests of paracetamol‐induced acute liver failure - CRAIG - 2010 - Alimentary Pharmacology & Therapeutics - Wiley Online Library Systematic review: prognostic tests of paracetamol‐induced acute liver failure - CRAIG - 2010 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2610e38d-cf80-4e34-9110-85d9fff702f0/apt_4279_f1.gif)
Systematic review: prognostic tests of paracetamol‐induced acute liver failure - CRAIG - 2010 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
![Evaluating the Platelet Distribution Width-to-Plateletcrit Ratio as a Prognostic Marker for Patients With Breast Cancer | Anticancer Research Evaluating the Platelet Distribution Width-to-Plateletcrit Ratio as a Prognostic Marker for Patients With Breast Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/7/3947/F1.large.jpg)
Evaluating the Platelet Distribution Width-to-Plateletcrit Ratio as a Prognostic Marker for Patients With Breast Cancer | Anticancer Research
![COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome - Journal of the Neurological Sciences COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome - Journal of the Neurological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b4d52a0d-5176-426d-99c7-dbe6cddc93e3/gr1.jpg)
COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome - Journal of the Neurological Sciences
![SCLERAXIS AS A PROGNOSTIC MARKER OF MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY (SPARC) STUDY - Canadian Journal of Cardiology SCLERAXIS AS A PROGNOSTIC MARKER OF MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY (SPARC) STUDY - Canadian Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/14ffb86d-5d06-4b9a-87a4-40b5eb05972c/fx1_lrg.jpg)
SCLERAXIS AS A PROGNOSTIC MARKER OF MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY (SPARC) STUDY - Canadian Journal of Cardiology
![Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions - Gynecologic Oncology Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions - Gynecologic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/11237c77-21b0-47a9-90d7-5d5e593cbdae/gr1.jpg)
Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions - Gynecologic Oncology
![Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6604999/MediaObjects/41416_2009_Article_BF6604999_Fig1_HTML.gif)
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer
![Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings - Annals of Oncology Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1697af5f-871c-405d-895d-823bd582e940/gr1.jpg)
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings - Annals of Oncology
![High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients - Clinical Nutrition ESPEN High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients - Clinical Nutrition ESPEN](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/99e40aa8-00aa-4a73-a4cc-fbdbdc266dd1/gr1_lrg.jpg)